Robert L. Wolfert
- Physiology top 1%
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 9
-
- Prostate Cancer Treatment and Research 19
- Prostate Cancer Diagnosis and Treatment 14
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Molecular Biology top 5%
- Metabolomics and Mass Spectrometry Studies 5
-
- Lipoproteins and Cardiovascular Health 17
-
- Adipokines, Inflammation, and Metabolic Diseases 5
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
- Co-authors
- Harry G. RittenhouseRobert McCormackPeter SeubertSukanto SinhaIvan LieberburgD. H. S. DavisDale SchenkFred Esch
- Partner nations
- United StatesItalyGreece
In The Last Decade
Robert L. Wolfert
54 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Physiology 1.4k
- Cancer Research 706
- Pulmonary and Respiratory Medicine 1.4k
- Endocrinology, Diabetes and Metabolism 415
- Molecular Biology 1.7k
Countries citing papers authored by Robert L. Wolfert
This map shows the geographic impact of Robert L. Wolfert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Wolfert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Wolfert more than expected).
Fields of papers citing papers by Robert L. Wolfert
This network shows the impact of papers produced by Robert L. Wolfert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Wolfert. The network helps show where Robert L. Wolfert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert L. Wolfert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 226 | |
| 2 | 2014 | 100 | |
| 3 | 2009 | 38 | |
| 4 | 2009 | 19 | |
| 5 | 2008 | 83 | |
| 6 | 2008 | 11 | |
| 7 | 2007 | 59 | |
| 8 | 2007 | 60 | |
| 9 | Abstract 4036: Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Independently Predicts Incident Coronary Heart Disease (CHD) in an Apparently Healthy Older Population: The Rancho Bernardo Study | 2006 | 1 |
| 10 | 2006 | 110 | |
| 11 | 2006 | 40 | |
| 12 | 2006 | 42 | |
| 13 | 2005 | 74 | |
| 14 | 1999 | 93 | |
| 15 | 1999 | 98 | |
| 16 | 1999 | 97 | |
| 17 | 1996 | 52 | |
| 18 | 1996 | 17 | |
| 19 | 1994 | 1 | |
| 20 | 1990 | 103 |
About Robert L. Wolfert
Robert L. Wolfert is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry and Genetics, having authored 55 papers that have together received 4.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Lipoproteins and Cardiovascular Health (17 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Protease and Inhibitor Mechanisms (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). The work is most often cited by research in Physiology (1.4k citations), Cancer Research (706 citations), Pulmonary and Respiratory Medicine (1.4k citations), Endocrinology, Diabetes and Metabolism (415 citations) and Molecular Biology (1.7k citations). Robert L. Wolfert has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include Harry G. Rittenhouse, Robert McCormack, Peter Seubert, Sukanto Sinha, Ivan Lieberburg, D. H. S. Davis, Dale Schenk, Fred Esch, Michael Lee and Dennis J. Selkoe. Their work appears in journals such as The Prostate, Urology, The Journal of Urology, Clinical Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.